Cargando…
BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts
BACKGROUND: The transcription factor hypoxia-inducible factor-1 (HIF-1) pathway plays an important role in tumor response to cytotoxic treatments. We investigated the effects of a novel small molecule inhibitor of mitochondrial complex I and hypoxia-induced HIF-1 activity BAY-87-2243, on tumor micro...
Autores principales: | Helbig, Linda, Koi, Lydia, Brüchner, Kerstin, Gurtner, Kristin, Hess-Stumpp, Holger, Unterschemmann, Kerstin, Baumann, Michael, Zips, Daniel, Yaromina, Ala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262387/ https://www.ncbi.nlm.nih.gov/pubmed/25234922 http://dx.doi.org/10.1186/1748-717X-9-207 |
Ejemplares similares
-
BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I
por: Ellinghaus, Peter, et al.
Publicado: (2013) -
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth
por: Schöckel, Laura, et al.
Publicado: (2015) -
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
por: Koi, Lydia, et al.
Publicado: (2023) -
Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts
por: Gurtner, Kristin, et al.
Publicado: (2014) -
Analysis of clinical characteristics of 2243 with positive anti‐gastric parietal cell antibody
por: Guo, Yaping, et al.
Publicado: (2020)